Collectively, it can be deduced that EVA1A suppresses GBM cells proliferation by promoting autophagy through inhibiting the mTOR/RPS6KB1 pathway, which needs further confirmation in vivo [8] (Figure 2). Here, EVA1A is linked to glioblastoma.